Polyunsaturated fatty acids in the modulation of T-cell signalling

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 4-6, 2010, Pages 179-187

  Akhtar Khan, Naim ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DIACYLGLYCEROL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; OMEGA 3 FATTY ACID; PHOSPHOLIPASE A2; PROTEIN KINASE C; RAS PROTEIN; TRANSCRIPTION FACTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ANTIGEN PRESENTING CELL; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CALCIUM SIGNALING; CELL STIMULATION; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MECHANISM; ENZYME ACTIVATION; GENE TRANSLOCATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LIPID RAFT; LIPOGENESIS; MOLECULAR INTERACTION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PSORIASIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; DIGLYCERIDES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77951978594     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.02.023     Document Type: Article

References (123)

1. Lewis R.A., Austen K.F., Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Eng. J. Med. 1990, 323:645-655.
2. Lands W.E.M. Biosynthesis of prostaglandins. Ann. Rev. Nut. 1991, 11:41-60.
3. Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991, 54:438-463.
4. Serhan C.N. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J. Thromb. Haemost. 2009, 7(Suppl. 1):44-48.
5. P.C. Calder, Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale, Biochimie, 2009. (Epub ahead of print).
6. Kremer J.M. Clinical studies of omega-3 fatty acid suplementation in patients who have rheumatoid arthritis. Rheum. Dis. Clin. North Am. 1991, 17:391-402.
7. Nielsen G.L., Faarvang K.L., Thomsen B.S., Teglbjaerg K.L., Jensen L.T., Hansen T.M., Lervang H.H., Schmidt E.B., Dyerberg J., Ernst E. The effects of dietary supplementation with n-3 poly-unsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur. J. Clin. Invest. 1992, 22:687-691.
8. Skoldstam L., Borjesson O., Kjallman A., Seiving B., Akesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand. J. Rheumatol. 1992, 21:178-185.
9. Geusens P., Wouters C., Nijs J., Jiang Y., Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum. 1994, 37:824-829.
10. Yamashita N., Maruyama M., Yamazaki K., Hamazaki T., Yano S. Effect of eicosapentaenoic and docosahexaenoic acid on natural killer cell activity in human peripheral blood lymphocytes. Clin. Immunol. Immunopathol. 1991, 59:335-345.
11. Yaqoob P., Calder P.C. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell. Immunol. 1995, 163:120-128.
12. Endres S., Meydani S.N., Ghorbani R., Schindler R., Dinarello C.A. Dietary supplementation with dietary fatty acids suppresses IL-2 production and monocyte cell proliferation. J. Leuk. Biol. 1993, 54:599-603.
13. Meydani S.N., Endres S., Woods M.M., Golding B.R., Soo C., Morrill-Labrode A., Dinarello C., Gorbach S.L. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison bcetween young and older women. J Nutr. 1991, 121:547-555.
14. Jolly C.A., McMurray D.N., Chapkin R.S. Effect of dietary n-3 fatty acids on interleukin-2 and interleukin-2 receptor expression in activated murine lymphocytes. Prostagland. Leukot. Essent. Fatty Acids 1998, 58:289-293.
15. Bittiner S.B., Tucker W.F.G., Cartwright I., Bleehen S.S. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet 1988, i:378-380.
16. Bjorneboe A., Soyland E., Bjorneboe G.-E.A., Rajka G., Drevon C.A. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br. J. Dermatol. 1987, 117:463-469.
17. Bates D., Cartlidge N.E.F., French J.M., Jackson M.J., Nightingale S., Shaw D.A., Smith S., Woo E., Hawkins S.A., Millar J.H.D., Belin J., Conroy D.M., Gill S.K., Sidey M., Smith A.D., Thompson R.H.S., Zilkha K., Gale M., Sinclair H.M. A double-blind controlled trial of long chain n-3 polyinsatured fatty acids in the treatment of multiple sclerosis. J. Neurol. Neurosurg. Psychia. 1989, 52:18-22.
18. Calder P.C., Miles E.A. Fatty acids and atopic disease. Pediatr. Allergy Immunol. 2000, 13:29-36.
19. Anderson P., Delgado M. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders. J Cell Mol. Med. 2008, 12:1830-1847.
20. Lim A.K., Manley K.J., Roberts M.A., Fraenkel M.B. Fish oil for kidney transplant recipients. Cochrane Database Syst. Rev 2007, 18.
21. Calder P.C. Use of fish oil in parenteral nutrition: rationale and reality. Proc. Nutr. Soc. 2006, 65:264-277.
22. Cantrell D. T-cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 1996, 14:259-274.
23. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptor. Cell 1994, 76:263-274.
24. Clements J.L., Koretzky G.A. Recent developments in lymphocyte activation: linking kinases to downstream signaling events. J. Clin. Invest. 1999, 103:925-929.
25. Chan A.C., Iwashima M., Turck C.W., Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR ξ chain. Cell 1992, 71:649-662.
26. Sieh M., Batzer A., Schlessinger J., Weiss A. GRB2 and phospholipase C-gamma1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation. Mol. Cell. Biol. 1994, 14:4435-4442.
27. Berridge M.J. Inositol tris phosphate and calcium signalling. Nature 1993, 361(1993):315-325.
28. Ward G.W. CD28: a signalling perspective. Biochem. J. 1996, 318:361-377.
29. Goldyne M.E., Burrish G.E., Paubelle P., Borgeat P. Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways. J. Biol. Chem. 1984, 259:8815-8819.
30. Kurland J.L., Bockmann R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med. 1978, 147:952-957.
31. Leitenberg D., Balamuth F., Bottomly K. Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation. Semin. Immunol. 2001, 13(2001):129-138.
32. Miceli M.C., Moran M., Chung C.D., Patel V.P., Low T., Zinnanti W. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin. Immunol. 2001, 13:115-128.
33. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-41.
34. Fan Y.Y., Ly L.H., Barhoumi R., McMurray D.N., Chapkin R.S. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J. Immunol. 2004, 173:6151-6160.
35. Geyeregger R., Zeyda M., Zlabinger G.J., Waldhausl W., Stulnig T.M. Polyunsaturated fatty acids interfere with formation of the immunological synapse. J. Leukocyte Biol. 2005, 77:680-688.
36. Kim W., Fan Y.Y., Barhoumi R., Smith R., McMurray D.N., Chapkin R.S. n-3 polyunsaturated fatty acids suppress the localization and activation of signaling proteins at the immunological synapse in murine CD4+ T cells by affecting lipid raft formation. J. Immunol. 2008, 181:6236-6243.
37. Zeyda M., Staffler G., Horejsi V., Waldhausl W., Stulnig T.M. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids. J. Biol. Chem. 2002, 277:28418-28423.
38. Stulnig T.M., Huber J., Leitinger N., Imre E.-M., Angelisová P., Nowotny P., Waldhäusl W. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J. Biol. Chem. 2001, 276:37335-37340.
39. Zeyda M., Szekeres A.B., Säemann M.D., Geyeregger R., Stockinger H., Zlabinger G.J., Waldhäusl W., Stulnig T.M. Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation. J. Immunol. 2003, 170:6033-6039.
40. Zeyda M., Stulnig T.M. Lipid Rafts & Co.: an integrated model of membrane organization in T cell activation. Prog Lipid Res. 2006, 45:187-202.
41. Gorjão R., Hirabara S.M., de Lima T.M., Cury-Boaventura M.F., Curi R. Regulation of intrleukin-2 signaling by fatty acids in human lymphocytes. J Lipid Res. 2007, 48:2009-2019.
42. Chapkin R.S., McMurray D.N., Davidson L.A., Patil B.S., Fan Y.Y., Lupton J.R. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br. J. Nutr. 2008, 100:1152-1157.
43. Robinson D.R., Xu L.L., Knoell C.T., Tateno S., Olesiak W. Modification of spleen phospholipid fatty acid composition by dietary fish oil and by n-3 fatty acid ethyl esters. J. Lipid Res. 1993, 34:1423-1434.
44. Shaikh S.R., Dumaual A.C., Castillo A., LoCascio D., Siddiqui R.A., Stillwell W., Wassall S.R. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: a comparative NMR, DSC, AFM and detergent extraction study. Biophys. J. 2004, 87:1752-1766.
45. Denys A., Hichami A., Khan N.A. n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J. Lipid Res. 2005, 46:752-758.
46. 2. Annu. Rev. Biochem. 1995, 64:653-688.
47. 1 macrophages and Chinese hamster ovary cells. J. Biol. Chem. 1997, 272:8576-8580.
48. Le Gouvello S., Colard O., Theodorou J., Dismuth G., Tarantino N., Debre P. CD2 triggering stimulates a phospholipase A2 activity beside the phospholipase C pathway in human T lymphocytes. J. Immunol. 1990, 144:2359-2364.
49. Boilard E., Surette M.E. Anti-CD3 and concanavalin A-induced human T cell proliferation is associated with an increased rate of arachidonate-phospholipid remodeling. lack of involvement of group IV and group VI phospholipase A2 in remodeling and increased susceptibility of proliferating T cells to coA-independent transacylase inhibitor-induced apoptosis. J. Biol. Chem. 2001, 276:18321-18326.
50. Roshak A.K., Capper E., Stevenson C., Eichman C., Marshall L.A. Human calcium-independent phospholipase A2 mediates lymphocyte proliferation. J. Biol. Chem. 2000, 275:35692-35698.
51. Tessier C., Hichami A., Khan NA Implication of three isoforms of PLA(2) in human T-cell proliferation. FEBS Lett. 2002, 520:111-116.
52. Hichami A., Joshi B., Simonin A.M., Khan N.A. Role of three isoformes of phospholipase A2 in capacitative calcium influx in human T-cells. Eur. J. Biochem. 2002, 269:5557-5563.
53. 2+ current in human leukemic T-cells. Cell Regul. 1989, 1:99-112.
54. Negulescu P.A., Shastri N., Cahalan M.D. Intracellular calcium dependence of gene expression in single T-lymphocytes. Proc. Natl. Acad. Sci. USA 1994, 91:2873-2877.
55. Putney J.W. Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry. Cell Calcium 1997, 21:257-261.
56. Oh-hora M., Rao A. Calcium signaling in lymphocytes. Curr. Opin. Immunol. 2008, 20:250-258.
57. 2+ stores. Proc. Natl. Acad. Sci. USA 1993, 90(1993):6295-6299.
58. Hoth M., Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 1992, 355(1992):353-356.
59. 2+ pool in T-cells through a mechanism independent of phosphoinositide turnover. J. Biol. Chem. 1990, 265:902-907.
60. i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol. Pharmacol. 2007, 272:1545-1556.
61. Bonin A., Khan N.A. Regulation of calcium signalling by docosahexaenoic acid in human T-cells: implication of CRAC channels. J. Lipid Res. 2000, 41:277-284.
62. Denys A., Aires V., Hichami A., Khan N.A. Thapsigargin-stimulated MAP kinase phosphorylation via CRAC channels and PLD activation: inhibitory action of docosahexaenoic acid. FEBS Lett. 2004, 564:177-182.
63. Aires V., Hichami A., Moutairou K., Khan N.A. Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. Br. J. Pharmacol. 2003, 140:1217-1226.
64. Triboulot C., Hichami A., Denys A., Khan N.A. Dietary (n-3) polyunsaturated fatty acids exert antihypertensive effects by modulating calcium signaling in T cells of rats. J Nutr. 2001, 131:2364-2369.
65. Guermouche B., Yessoufou A., Soulimane N., Merzouk H., Moutairou K., Hichami A., Khan N.A. n-3 fatty acids modulate T-cell calcium signaling in obese macrosomic rats. Obes. Res. 2004, 12:1744-1753.
66. Stulnig T.M., Berger M., Sigmund T., Raederstorff D., Stockinger H., Waldhäusl W. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J. Cell Biol. 1998, 143:637-644.
67. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992, 258:607-614.
68. Nishizuka Y. Discovery and prospect of protein kinase C research: epilogue. J. Biochem. 2003, 133:155-158.
69. Khan N.A., Quemener V., Moulinoux J.P. Phorbol esters augment spermidine transport without protein kinase C activation. Biochem. Pharmacol. 1990, 40:R1-R4.
70. Kiley S.C., Jaken S. Protein kinase C: interactions and consequences. Trends Cell Biol. 1994, 4:223-227.
71. Yoshida K., Asaoka Y., Nishizuka Y. Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acid. Proc. Natl. Acad. Sci. USA 1992, 89:6443-6446.
72. 2+-dependent protein kinase. Science 1984, 224:622-625.
73. 2 in signal transduction through protein kinase C. Proc. Natl. Acad. Sci. USA 1991, 88:5149-5153.
74. May C., Southworth A.J., Calder P.C. Inhibition of lymphocyte protein kinase C by unsaturated fatty acids. Biochem. Biophys. Res. Commun. 1993, 195:823-828.
75. Rossetti R.G., Seiler C.M., Laposata M., Zurier R.B. Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids. Clin. Immunol. Immunopathol. 1995, 76:220-224.
76. Speizer L.A., Watson M.J., Brunton L.L Differential effects of omega-3 fish oils on protein kinase activities in vitro. Am. J. Physiol. 1991, 261(Endocrinol. Metab. 24):E109-E114.
77. Denys A., Hichami A., Khan N.A. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. J Lipid Res. 2001, 42:2015-2020.
78. Robbins D.J., Zhen E., Cheng M., Xu S., Ebert D., Cobb M.H. MAP kinases ERKI and ERK2: pleiotropic enzymes in a ubiquitous signalling network. Adv. Cancer Res. 1994, 63:93-116.
79. Whitehurst C.E., Geppert D. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 1996, 156:1020-1029.
80. Rincón M., Flavell R.A, Davis R.J. Signal transduction by MAP kinases in T lymphocytes. Oncogene 2001, 20:2490-2497.
81. Hii C.S.T., Ferrante A., Edwards Y.S., Huang Z.H., Hartfield P.J., Rathjen D.A., Poulos A., Murray A.W. Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism. J. Biol. Chem. 1995, 270:4201-4204.
82. Rao G.N., Baas A.S., Glagow W.C., Eling T.E., Runge M.S., Alexander R.W. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 1994, 269:32586-32591.
83. Dulin N.O., Sorokin A.S., Douglas J.G. Arachidonate-induced tyrosine phosphorylation of epidermal growth factor receptor and Shc-Grb2-Sos association. Hypertension 1998, 32:1089-1093.
84. Barry O.P., Kazanietz M.G., Pratico D., FitzGerald G.A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 1999, 274:7545-7556.
85. Denys A., Hichami A., Khan N.A. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol. Cell Biochem. 2002, 232:143-148.
86. Denys A., Hichami A., Maume B., Khan N.A. Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells. Lipids 2001, 36:813-818.
87. Massaro A., Habib L., Lubrano S.D., Turco G., Lazzerini T., Bourcier B.B., Weksler R. De Caterina, The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC{varepsilon} inhibition. Proc. Natl. Acad. Sci. USA 2006, 103:15184-15189.
88. Hagiwara S., Makita Y., Gu L., Tanimoto M., Zhang M., Nakamura S., Kaneko S., Itoh T., Gohda T., Horikoshi S., Tomino Y. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. Nephrol. Dial. Transplant 2006, 21:605-615.
89. Kim H.H., Shin C.M., Park C.-H., Kim K.H., Cho K.H., Eun H.C., Chung J.H. Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts. J. Lipid Res. 2005, 46:1712-1720.
90. Lo C.J., Chiu K.C., Fu M., Chu A., Helton S. Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide. J. Parenter. Enter. Nutr. 2000, 24:159-163.
91. Bousserouel S., Brouillet A., Bereziat G., Raymondjean M., Andreani M. Different effects of n-6 and n-3 polyunsaturated fatty acids on the activation of rat smoothmuscle cells by interleukin-1Β. J. Lipid Res. 2003, 44:601-611.
92. Yessoufou A., Plé A., Moutairou K., Hichami A., Khan N.A. DHA reduces suppressive and migratory functions of Treg cells. J. Lipid Res. 2009, 27. [Epub ahead of print].
93. Bechoua S., Dubois M., Némoz G., Lagarde M., Prigent A.F. Docosahexaenoic acid lowers phosphatidate level in human activated lymphocytes despite phospholipase D activation. J Lipid Res. 1998, 39:873-883.
94. Madani S., Hichami A., Cherkaoui-Malki M., Khan N.A. Diacylglycerols containing Omega 3 and Omega 6 fatty acids bind to RasGRP and modulate MAP kinase activation. J. Biol. Chem. 2004, 279:1176-1183.
95. Fowler K.H., McMurray D.N., Fan Y.Y., Aukema H.M., Chapki R.S. Purified dietary n-3 polyunsaturated fatty acids alter diacylglycerol mass and molecular species composition in concanavalin A-stimulated murine splenocytes. Biochim. Biophys. Acta 1993, 1210:89-96.
96. Montell C. Drosophila TRP channels. Pflugers Arch. 2005, 451:19-28.
97. Hofmann T., Obukhov A.G., Schaefer M., Harteneck C., Gudermann T., Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999, 397:259-263.
98. Gamberucci A., Giurisato E., Pizzo P., Tassi M., Giunti R., McIntosh D.P., Benedetti A. Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products. Biochem. J. 2002, 364:245-254.
99. Aires V., Hichami A., Boulay G., Khan N.A. Activation of TRPC6 calcium channels by diacylglycerol (DAG)-containing arachidonic acid: a comparative study with DAG-containing docosahexaenoic acid. Biochimie 2007, 89:926-937.
100. Izquierdo M., Downward J., Graves J.D., Cantrell D.A. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells. Mol. Cell. Biol. 1992, 12:3305-3312.
101. Downward J. Regulation of p21ras by GTPase activating proteins and guanine nucleotide exchange proteins. Curr. Opin. Genet. Dev. 1992, 2:13-18.
102. Zhang X.F., Kyriakis J.M., Takeuchi-Suzuki E., Elledge E., Marchall M.S., Bruder J.T., Rapp U., Avruch J. Normal and oncogenic p21 ras proteins bind to the amino acid terminal regulatory domain of c-Raf-1. Nature 1993, 364:308-313.
103. Kyriakis J.M., App H., Zhang X.F., Banerjee P., Brautigan D.L., Rapp U.R., Avruch J., Raf-1 J. activates MAP kinase-kinase. Nature 1992, 358:417-421.
104. Ebinu O., Bottorff D.A., Chan E.Y., Stang S.L., Dunn R.J., Stone J.C. RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 1998, 280(1998):1082-1086.
105. Lorenzo P.S., Beheshti M., Pettit G.R., Stone J.C., Blumberg P.M. The guanine nucleotide exchange factor RasGRP is a high -affinity target for diacylglycerol and phorbol esters. Mol. Pharmacol. 2000, 57:840-846.
106. Marignani P.A., Epand R.M., Sebaldt R.J. Acyl chain dependence of diacylglycerol activation of protein kinase C activity in vitro. Biochem. Biophys. Res. Commun. 1996, 225:469-473.
107. Ziboh V.A., Miller C.C., Cho Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am. J. Clin. Nutr. 2000, 71:361S-366S.
108. Bordoni A., Biagi P.L., Turchetto E., Rossi C.A., Hrelia S. The correlation between the acidic composition of diacylglycerol and protein kinase C activation in cultures of rat cardiomyocytes. Cardiologia 1992, 37:631-634.
109. Jolly C.A., Jiang Y.H., Chapkin R.S., McMurray D.N. Dietary n-3 polyunsaturated fatty acid modulation of murine lymphoproliferation and interleukin-2 secretion: correlation with alteration in diacylglycerol and ceramide mass. J. Nutr. 1997, 127:37-43.
110. McMurray D.N., Jolly C.A., Chapkin R.S. Effect of dietary n-3 fatty acids on T cell activation and T cell receptor mediated signalling in a murine model. J. Infect Dis. 2000, 182:S103-S107.
111. Madani S., Hichami A., Legrand A., Belleville J., Khan N.A. Implication of acyl chain of diacylglycerols in activation of different isoforms of protein kinase C. FASEB J. 2001, 15(2001):2595-2601.
112. Judé S., Martel E., Vincent F., Besson P., Couet C., Ogilvie G.K., Pinault M., De Chalendar C., Bougnoux P., Richard S., Champeroux P., Crozatier B., Le Guennec J.Y. Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocation. Br. J. Nutr. 2007, 98:1143-1151.
113. Cooper J.A. Straight and narrow or tortuous and intersecting?. Curr. Biol. 1994, 4:1118-1121.
114. Ly L.H., Smith R., Switzer K.C., Chapkin R.S., McMurray D.N. Dietary eicosapentaenoic acid modulates CTLA-4 expression in murine CD4+ T-cells. Prostagland. Leukot. Essent. Fatty Acids 2006, 74:29-37.
115. Ly L.H., Smith R., Chapkin R.S., McMurray D.N. Dietary n-3 polyunsaturated fatty acids suppress splenic CD4(+) T cell function in interleukin (IL)-10(-/-) mice. Clin. Exp. Immunol. 2005, 139:202-209.
116. Imboden J., Weyand C., Goronzy J. Antigen recognition by a human T cell clone leads to increases in inositol trisphosphate. J Immunol. 1987, 138:1322-1324.
117. Billah M.M., Anthes J.C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J. 1990, 269:281-291.
118. Khan N.A., Hichami A. Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospholipase D pathway in human T-cells. Biochem. J. 1999, 344:199-204.
119. El Bawab S., Macovschi O., Thevenon C., Goncalves A., Némoz G., Lagarde M., Prigent A.F. Contribution of phosphoinositides and phosphatidylcholines to the production of phosphatidic acid upon concanavalin A stimulation of rat thymocytes. J. Lipid Res. 1996, 37:2098-2108.
120. Jain J., Loh C., Rao A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 1995, 7:333-342.
121. Diep Q.N., Touyz R.M., Schiffrin E.L. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-{alpha} ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 2000, 36:851-855.
122. Avula C.P., Zaman A.K., Lawrence R., Fernandes G. Induction of apoptosis and apoptotic mediators in balb/c splenic lymphocytes by dietary n-3 and n-6 fatty acids. Lipids 1999, 34:921-927.
123. Zong Z.P., Matsui S., Han J.F., Katsuda S., Fu M.L. Involvement of thymus in amiodarone-treated autoimmune myocarditis in rat. Int. J. Cardiol. 2008, 125:122-129.